Retina

In a presentation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Lu, MD, a retina specialist at Johns Hopkins Medicine, discussed the application of large language models (LLMs) in revenue cycle management (RCM).

Michael Singer, MD, shared insights from on his experience using a preservative-free, chloroprocaine ophthalmic gel as anesthesia for intravitreal injections and the results of research on the effectiveness of gel versus traditional drops.

At this year's American Academy of Ophthalmology (AAO) meeting, Jonathan Brugger, MD, spoke about the changing approach to epimacular membranes and the use of brilliant blue in the procedure.

In the first five months of the program at Henrietta Johnson Medical Center, 26% of patients with images gradable by EyeArt tested positive for either more-than-mild or vision-threatening diabetic retinopathy.

This initiative is supported by a $5 million grant from the Knights Templar Eye Foundation.

A home self-imaging device can provide ophthalmologists with actionable insight between office visits for AMD

AEYE Health will attend the American Academy of Ophthalmology (AAO) Annual Meeting, from October 18-21 in Chicago.

Applied Science, Inc. (ASI) is expanding its AdaptivMD chronic care workflow technology

A team of researchers at Arizona State University has developed tools to aid in the diagnosis of myopic maculopathy.

In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts disease-risk factors from 3D medical-scan modalities.

Marketed as Triesence, it is a preservative-free synthetic corticosteroid that is approved by the FDA for visualization during vitrectomy and for the treatment of ocular inflammatory conditions that are unresponsive to topical corticosteroids.

The company’s flagship product is Reti-CVD, an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using a retina scan.

Digital exclusive article on red-blue-green ultrawidefield (UWF) imaging

The general secretary of the European Society of Retina Specialists (EURETINA) says the future of AI is here

Dvey-Aharon is an internationally known AI expert and the inventor of AEYE-DS.

Carl Awh, MD, FASRS, spoke about the presence of members of the American Society of Retina Specialists (ASRS) attending the EURETINA meeting and the value of the international community of retina clinicians connecting at meetings around the globe.

Zhang’s journey as the first retina optometrist in Colorado

Retina is a rapidly advancing field with promising research, technology, and treatment areas. Two stand out as particularly exciting.

Researchers from NYU Langone published a study reporting on the eye's functioning, without sight but offering hope for the future.

The contract research organization and technology solution is for the execution of ophthalmology clinical trials.

APP13007, according to the company, is the first product developed using Formosa’s proprietary APNT nanoparticle formulation platform.

This certification covers AI based regulatory requirements for the company's platform for AI imaging and diagnostic tools.

Australian researchers have found that clinical registries may be an untapped font of information for artificial intelligence.